Jazz Pharmaceuticals (JAZZ) Competitors $119.24 +2.42 (+2.07%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends JAZZ vs. IONS, RARE, MRTX, SRPT, RPRX, CORT, PRGO, SUPN, PCRX, and OMERShould you be buying Jazz Pharmaceuticals stock or one of its competitors? The main competitors of Jazz Pharmaceuticals include Ionis Pharmaceuticals (IONS), Ultragenyx Pharmaceutical (RARE), Mirati Therapeutics (MRTX), Sarepta Therapeutics (SRPT), Royalty Pharma (RPRX), Corcept Therapeutics (CORT), Perrigo (PRGO), Supernus Pharmaceuticals (SUPN), Pacira BioSciences (PCRX), and Omeros (OMER). These companies are all part of the "pharmaceutical preparations" industry. Jazz Pharmaceuticals vs. Ionis Pharmaceuticals Ultragenyx Pharmaceutical Mirati Therapeutics Sarepta Therapeutics Royalty Pharma Corcept Therapeutics Perrigo Supernus Pharmaceuticals Pacira BioSciences Omeros Ionis Pharmaceuticals (NASDAQ:IONS) and Jazz Pharmaceuticals (NASDAQ:JAZZ) are both mid-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, valuation, community ranking, media sentiment, analyst recommendations, profitability, institutional ownership and risk. Do analysts prefer IONS or JAZZ? Ionis Pharmaceuticals currently has a consensus target price of $60.65, indicating a potential upside of 71.32%. Jazz Pharmaceuticals has a consensus target price of $175.53, indicating a potential upside of 47.21%. Given Ionis Pharmaceuticals' higher possible upside, analysts clearly believe Ionis Pharmaceuticals is more favorable than Jazz Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ionis Pharmaceuticals 1 Sell rating(s) 5 Hold rating(s) 12 Buy rating(s) 1 Strong Buy rating(s) 2.68Jazz Pharmaceuticals 0 Sell rating(s) 3 Hold rating(s) 12 Buy rating(s) 0 Strong Buy rating(s) 2.80 Which has higher valuation and earnings, IONS or JAZZ? Jazz Pharmaceuticals has higher revenue and earnings than Ionis Pharmaceuticals. Ionis Pharmaceuticals is trading at a lower price-to-earnings ratio than Jazz Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIonis Pharmaceuticals$788M7.09-$366.29M-$2.44-14.51Jazz Pharmaceuticals$3.99B1.81$414.83M$7.1016.79 Does the media favor IONS or JAZZ? In the previous week, Jazz Pharmaceuticals had 6 more articles in the media than Ionis Pharmaceuticals. MarketBeat recorded 18 mentions for Jazz Pharmaceuticals and 12 mentions for Ionis Pharmaceuticals. Jazz Pharmaceuticals' average media sentiment score of 0.65 beat Ionis Pharmaceuticals' score of 0.10 indicating that Jazz Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Ionis Pharmaceuticals 3 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral Jazz Pharmaceuticals 7 Very Positive mention(s) 3 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive Is IONS or JAZZ more profitable? Jazz Pharmaceuticals has a net margin of 11.60% compared to Ionis Pharmaceuticals' net margin of -44.58%. Jazz Pharmaceuticals' return on equity of 29.30% beat Ionis Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Ionis Pharmaceuticals-44.58% -88.98% -12.42% Jazz Pharmaceuticals 11.60%29.30%9.72% Does the MarketBeat Community prefer IONS or JAZZ? Jazz Pharmaceuticals received 425 more outperform votes than Ionis Pharmaceuticals when rated by MarketBeat users. Likewise, 80.66% of users gave Jazz Pharmaceuticals an outperform vote while only 60.21% of users gave Ionis Pharmaceuticals an outperform vote. CompanyUnderperformOutperformIonis PharmaceuticalsOutperform Votes69360.21% Underperform Votes45839.79% Jazz PharmaceuticalsOutperform Votes111880.66% Underperform Votes26819.34% Which has more risk and volatility, IONS or JAZZ? Ionis Pharmaceuticals has a beta of 0.39, indicating that its stock price is 61% less volatile than the S&P 500. Comparatively, Jazz Pharmaceuticals has a beta of 0.57, indicating that its stock price is 43% less volatile than the S&P 500. Do institutionals & insiders hold more shares of IONS or JAZZ? 93.9% of Ionis Pharmaceuticals shares are held by institutional investors. Comparatively, 89.1% of Jazz Pharmaceuticals shares are held by institutional investors. 2.7% of Ionis Pharmaceuticals shares are held by company insiders. Comparatively, 4.2% of Jazz Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. SummaryJazz Pharmaceuticals beats Ionis Pharmaceuticals on 14 of the 18 factors compared between the two stocks. Ad Darwin2025 AI Stock Picks: 2 Hidden Gems Under $10/ShareThe AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.👉[Click here to get your FREE report delivered instantly!] Get Jazz Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for JAZZ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart JAZZ vs. The Competition Export to ExcelMetricJazz PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$7.06B$6.41B$5.01B$8.81BDividend YieldN/A8.11%5.16%4.06%P/E Ratio16.7910.57134.3717.77Price / Sales1.81243.641,158.6875.18Price / Cash4.3722.1633.5332.53Price / Book2.015.474.674.68Net Income$414.83M$153.61M$119.07M$226.08M7 Day Performance-4.05%-2.00%-1.83%-1.04%1 Month Performance5.41%-7.47%-3.62%1.04%1 Year Performance0.82%31.80%31.63%26.28% Jazz Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)JAZZJazz Pharmaceuticals4.9172 of 5 stars$119.24+2.1%$175.53+47.2%-1.2%$7.06B$3.83B16.792,800Analyst ForecastIONSIonis Pharmaceuticals4.2197 of 5 stars$35.40+4.9%$60.65+71.3%-28.7%$5.33B$788M0.00800RAREUltragenyx Pharmaceutical4.6401 of 5 stars$46.40+2.8%$86.69+86.8%+17.9%$4.17B$434.25M0.001,276MRTXMirati Therapeutics0.5607 of 5 stars$58.70flat$59.00+0.5%N/A$4.12B$12.44M-4.80587Analyst ForecastSRPTSarepta Therapeutics4.9373 of 5 stars$110.86+4.0%$181.33+63.6%+33.5%$10.18B$1.64B88.691,314Analyst DowngradeGap UpRPRXRoyalty Pharma4.7205 of 5 stars$26.22+0.8%$41.67+58.9%-2.6%$15.32B$2.36B13.5980CORTCorcept Therapeutics4.6673 of 5 stars$56.09+3.3%$65.25+16.3%+116.2%$5.69B$482.38M44.52300PRGOPerrigo4.9798 of 5 stars$27.15-0.3%$37.00+36.3%-10.8%$3.72B$4.66B0.009,140Positive NewsSUPNSupernus Pharmaceuticals2.3042 of 5 stars$36.12+1.7%$36.00-0.3%+32.3%$1.96B$607.52M33.76580Positive NewsPCRXPacira BioSciences3.9929 of 5 stars$17.03+1.8%$23.50+38.0%-38.5%$772.48M$674.98M0.00720Positive NewsOMEROmeros3.6817 of 5 stars$6.03flat$9.00+49.3%+244.6%$349.44MN/A0.00198Analyst Upgrade Related Companies and Tools Related Companies IONS Alternatives RARE Alternatives MRTX Alternatives SRPT Alternatives RPRX Alternatives CORT Alternatives PRGO Alternatives SUPN Alternatives PCRX Alternatives OMER Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:JAZZ) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jazz Pharmaceuticals plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Jazz Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
